NeuroMetrix Announces China Launch of Peripheral Neuropathy Diagnostic

NeuroMetrix, a US medical device maker, announced it will begin the China launch of DPNCheck ® , a diagnostic test for peripheral neuropathy. The device was approved by the CFDA in January. A Class II Medical Device, DPNCheck measures sural nerve conduction velocity in the leg, a biomarker for peripheral neuropathy. The device will be introduced at the 20 th Scientific Meeting of the Chinese Diabetes Society during November 16-19, 2016 in Xiamen, Fujian. Omron Beijing will market the device for NeuroMetrix in China. More details.... Stock Symbol: (NSDQ: NURO) Share this with colleagues: // //